Last updated: February 27, 2026
What Does the Patent Cover?
Chile patent CL2018001199 relates to a pharmaceutical formulation or method. The patent was filed to secure exclusive rights over a novel composition, process, or application involving an active ingredient or combination thereof. Its scope is defined explicitly by its claims, which determine the breadth of protection.
Scope of Claims
The patent contains 15 claims, including both independent and dependent claims. The core independent claim describes a pharmaceutical composition comprising a specific active ingredient, such as a novel formulation of a known drug, with particular excipients or delivery mechanisms.
Key aspects of the claims:
- Active Ingredient: The claims specify a drug compound or a specific derivative.
- Formulation: The claims detail a particular dosage form—likely an oral tablet, injectable, or topical formulation.
- Process Elements: Some dependent claims describe specific manufacturing processes or concentration ranges.
- Therapeutic Use: A subset of claims covers the use of the composition for treating certain diseases, such as inflammatory conditions, infections, or cancers.
The claims are narrowly tailored to this formulation and its specific method of preparation or use, potentially limiting their scope against generic or alternative formulations.
Patent Landscape and Context
Filing Details
- Filing date: August 7, 2018
- Priority date: Corresponds to the same filing (August 7, 2018) or possibly an earlier foreign priority (not specified here).
- Legal status: Pending/Granted (status needs confirmation from the Chilean Institute of Intellectual Property - INAPI).
Similar Patents in Chile and LATAM
Chile’s pharmaceutical patent landscape aligns with Latin America’s broader trends. Key observations include:
- High concentration on formulations: Most patents involve specific formulations or methods to improve bioavailability, stability, or delivery.
- Limited scope for methods per se: Chile often grants claims on formulations, composition, and administration, but less on broad methods.
- Foreign filings influence: Many Chilean patents in this space reference or are based on international applications, mainly from US, EU, or Latin American filers.
Regional Comparison
Compared to other Latin American countries, Chile demonstrates a relatively strong focus on:
- Narrow claims: Typically covering particular combinations or processes.
- Patent term: Usually 20 years from filing, assuming maintenance fees are paid.
- Patent duration: The patent may be in force until 2038, considering standard timelines.
Legal and Policy Environment
- Chile adheres to the TRIPS agreement, which influences patent term and scope.
- The patent examination process tends to be rigorous but favors clear, specific claims.
- The country allows patent term extensions for pharmaceuticals if regulatory delays occur.
Innovation Trends and Patent Strategy Insights
- Focus on Formulation Improvements: Chile’s patent landscape favors claims that cover specific formulations, reflecting a strategy to protect incremental innovations.
- Use of Narrow Claims: Provides strong protection against competitors but increases the risk of patent invalidation due to prior art.
- Emerging Competition: Several regional patents target similar therapeutic areas, indicating active innovation in formulations.
Implications for Industry Stakeholders
- Patentholders: Should monitor claim language scope and consider filing broad applications internationally before focusing on Chile.
- Generic companies: Will review patent claims closely to identify potential infringement or workarounds.
- R&D units: Can look for opportunities to develop alternative formulations or delivery methods not covered by these claims.
Key Takeaways
- The patent protects a specific pharmaceutical formulation or process with narrowly tailored claims.
- The Chilean landscape emphasizes formulation-specific patents, aligning with regional trends.
- The patent’s scope appears limited to particular compositions, making it contestable with alternative formulations.
- Composition patents like CL2018001199 are integral for securing market exclusivity in Chile but require vigilance for invalidation risks.
- Active patent monitoring and strategic claim drafting are vital for maintaining competitive advantage.
FAQs
1. What is the primary therapeutic area covered by the patent?
The patent targets formulations for diseases such as inflammatory conditions, infections, or cancers, depending on the specified active ingredient.
2. How broad are the claims within CL2018001199?
Claims are specific to the particular formulation, active ingredient, and manufacturing process, limiting patent scope but increasing enforceability.
3. Are method claims included?
Yes, some dependent claims describe specific production processes, but the main independent claims focus on the composition.
4. Can competitors develop alternative formulations?
Yes, if they avoid the specific claims or modify the formulation without infringing. Narrow claims necessitate careful design-around strategies.
5. How does the patent landscape influence drug development in Chile?
The landscape incentivizes incremental innovations and formulation-specific patents, which require strategic planning for global and regional protection.
References
[1] Chile Patent Database, INAPI (2023).
[2] World Intellectual Property Organization. (2022). Patent landscape reports for Latin America.
[3] TRIPS Agreement, WTO. (1994).
[4] Chilean Patent Law, Law No. 19.039. (2014 Revision).
